1. Home
  2. BHK vs FTRE Comparison

BHK vs FTRE Comparison

Compare BHK & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHK
  • FTRE
  • Stock Information
  • Founded
  • BHK 2001
  • FTRE 1996
  • Country
  • BHK United States
  • FTRE United States
  • Employees
  • BHK N/A
  • FTRE N/A
  • Industry
  • BHK Finance Companies
  • FTRE Medical Specialities
  • Sector
  • BHK Finance
  • FTRE Health Care
  • Exchange
  • BHK Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • BHK 551.8M
  • FTRE 469.0M
  • IPO Year
  • BHK N/A
  • FTRE N/A
  • Fundamental
  • Price
  • BHK $9.73
  • FTRE $5.19
  • Analyst Decision
  • BHK
  • FTRE Hold
  • Analyst Count
  • BHK 0
  • FTRE 11
  • Target Price
  • BHK N/A
  • FTRE $17.10
  • AVG Volume (30 Days)
  • BHK 188.3K
  • FTRE 2.5M
  • Earning Date
  • BHK 01-01-0001
  • FTRE 08-11-2025
  • Dividend Yield
  • BHK 8.34%
  • FTRE N/A
  • EPS Growth
  • BHK N/A
  • FTRE N/A
  • EPS
  • BHK 1.03
  • FTRE N/A
  • Revenue
  • BHK N/A
  • FTRE $2,685,600,000.00
  • Revenue This Year
  • BHK N/A
  • FTRE N/A
  • Revenue Next Year
  • BHK N/A
  • FTRE $1.36
  • P/E Ratio
  • BHK $10.42
  • FTRE N/A
  • Revenue Growth
  • BHK N/A
  • FTRE N/A
  • 52 Week Low
  • BHK $9.02
  • FTRE $3.97
  • 52 Week High
  • BHK $11.09
  • FTRE $28.41
  • Technical
  • Relative Strength Index (RSI)
  • BHK 42.97
  • FTRE 48.05
  • Support Level
  • BHK $9.55
  • FTRE $4.92
  • Resistance Level
  • BHK $9.75
  • FTRE $5.46
  • Average True Range (ATR)
  • BHK 0.11
  • FTRE 0.44
  • MACD
  • BHK 0.02
  • FTRE 0.02
  • Stochastic Oscillator
  • BHK 60.36
  • FTRE 16.16

About BHK Blackrock Core Bond Trust

Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: